Anthony Joshua U.S. fight in doubt after Miller’s positive drug test
Anthony Joshua’s American debut is in jeopardy after his challenger Jarrell “Big Baby” Miller allegedly tested positive for a banned substance.
ESPN first reported Miller failed a doping test for banned substance GW1516, citing three sources with knowledge of the results.
The heavyweights were scheduled to fight on June 1 at New York’s Madison Square Garden, with Joshua (22-0) defending his WBA, WBO and IBF heavyweight titles.
Ahead of the fight, the pre-sale tickets broke an MSG record — and it took only two hours to become the highest grossing pre-sale in the history of the arena.
“Heavyweight contender Jarrell ‘Big Baby’ Miller has tested positive for the banned substance GW1516 ahead of his scheduled challenge of unified world titleholder Anthony Joshua, three sources with knowledge of the results told ESPN on Tuesday night,” Rafael tweeted.
“The results, which came to light on Tuesday, were from a random Voluntary Anti-Doping Association-conducted urine test Miller submitted to on March 20.”
GW1516, also known as cardarine and endurobol, is on the World Anti-Doping Agency’s banned list and classified as a metabolic modulator. An athlete might use it to assist in fat loss or use it as an endurance booster, per ESPN.
Joshua’s promoter Eddie Hearn confirmed the report but said his fighter’s “preparation continues” for the big date.
We have been informed by VADA that there has been an adverse finding in Jarrell Miller’s sample collected on March 20th, 2019. We are working with all relevant parties and will update with more details soon. AJ’s preparation continues for June 1st at MSG.
— Eddie Hearn (@EddieHearn) April 17, 2019